Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00039
|
|||||
Drug Name |
Glutathione
|
|||||
Synonyms |
5-L-Glutamyl-L-cysteinylglycine; 70-18-8; Agifutol S; Copren; Deltathione; GSH; Glutathion; Glutathione; Glutathione (reduced); Glutathione SH; Glutathione [JAN]; Glutathione-SH; Glutatiol; Glutatione; Glutide; Glutinal; Isethion; L-Glutathione reduced; L-Glutatione; L-gamma-glutamyl-L-cysteinylglycine; Ledac; Neuthion; Panaron; Tathion; Tathione; Triptide; gamma-L-Glutamyl-L-cysteinylglycine; gamma-L-Glutamylcysteinylglycine; gamma-L-glutamyl-L-cysteinyl-glycine; glutathione red; red. glutathione; reduced glutathione
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Human immunodeficiency virus infection [ICD11: 1C62.Z] | Approved | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C10H17N3O6S
|
|||||
Canonical SMILES |
C(CC(=O)NC(CS)C(=O)NCC(=O)O)C(C(=O)O)N
|
|||||
InChI |
InChI=1S/C10H17N3O6S/c11-5(10(18)19)1-2-7(14)13-6(4-20)9(17)12-3-8(15)16/h5-6,20H,1-4,11H2,(H,12,17)(H,13,14)(H,15,16)(H,18,19)/t5-,6-/m0/s1
|
|||||
InChIKey |
RWSXRVCMGQZWBV-WDSKDSINSA-N
|
|||||
CAS Number |
CAS 70-18-8
|
|||||
Pharmaceutical Properties | Molecular Weight | 307.33 | Topological Polar Surface Area | 160 | ||
Heavy Atom Count | 20 | Rotatable Bond Count | 9 | |||
Hydrogen Bond Donor Count | 6 | Hydrogen Bond Acceptor Count | 8 | |||
XLogP |
-4.5
|
|||||
PubChem CID | ||||||
PubChem SID |
3133343
, 3353
, 5486
, 584925
, 585393
, 585424
, 585868
, 597405
, 6435995
, 7847082
, 7887988
, 8011661
, 8019868
, 8022090
, 818762
, 820159
, 820986
, 821009
, 821976
, 821977
, 823584
, 823921
, 823937
, 823938
, 823940
, 823941
, 823951
, 824192
, 824837
, 825748
, 828541
, 828542
, 829059
, 829900
, 831498
, 833160
, 834720
, 835369
, 836320
, 836434
, 836436
, 836441
, 836516
, 837543
, 838218
, 838751
, 838765
, 841095
, 854378
, 855260
|
|||||
ChEBI ID |
ChEBI:16856
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
MRP1 | Transporter Info | Multidrug resistance-associated protein 1 | Substrate | [3] | ||
MRP2 | Transporter Info | Multidrug resistance-associated protein 2 | Substrate | [4] | ||
MRP4 | Transporter Info | Multidrug resistance-associated protein 4 | Substrate | [5] | ||
OATP1B3 | Transporter Info | Organic anion transporting polypeptide 1B3 | Substrate | [6] | ||
P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [7] | ||
Drug-Transporter Activity Data | ||||||
Drug-Transporter Activity Data | MRP1 | Transporter Info | Km = 5000 microM | Human cervical cancer cell line (Hela)-MRP1 | [8] | |
References | ||||||
1 | Glutathione was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Glutathione transport is a unique function of the ATP-binding cassette protein ABCG2. J Biol Chem. 2010 May 28;285(22):16582-7. | |||||
3 | Structural determinants of substrate specificity differences between human multidrug resistance protein (MRP) 1 (ABCC1) and MRP3 (ABCC3). Drug Metab Dispos. 2008 Dec;36(12):2571-81. | |||||
4 | Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway. Hepatology. 2007 Nov;46(5):1597-610. | |||||
5 | Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues. Biochem J. 2002 Feb 1;361(Pt 3):497-503. | |||||
6 | Regulation of Organic Anion Transporting Polypeptides (OATP) 1B1- and OATP1B3-Mediated Transport: An Updated Review in the Context of OATP-Mediated Drug-Drug Interactions. Int J Mol Sci. 2018 Mar 14;19(3). pii: E855. | |||||
7 | Upregulation of cellular glutathione levels in human ABCB5- and murine Abcb5-transfected cells. BMC Pharmacol Toxicol. 2015 Dec 15;16:37. | |||||
8 | Topological polar surface area defines substrate transport by multidrug resistance associated protein 1 (MRP1/ABCC1). J Med Chem. 2009 Feb 26;52(4):1214-8. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.